Matz Marilyn, a director at Teradyne, Inc., has reported the sale of 400 shares of the company’s common stock. The transaction, which took place on October 21, 2026, is part of a structured sales plan established to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. This move is significant as it reflects the ongoing activity within the executive ranks of Teradyne, a key player in the instruments for measuring and testing industry.
Teradyne, Inc. is a prominent company specializing in the manufacturing of equipment used for measuring and testing electrical signals. The company is listed under the Central Index Key 0000097210 and operates in the industrial applications and services sector. It is headquartered in North Reading, Massachusetts, and has a fiscal year ending on December 31.
The filing indicates that Matz Marilyn disposed of the shares at a price of $350 per share, resulting in a total transaction value of $140,000. Following this sale, Matz retains ownership of approximately 12,640.675 shares of Teradyne. The structured sales plan adopted by Matz on February 13, 2026, aims to facilitate orderly selling while adhering to regulatory standards.
This transaction may affect investor sentiment towards Teradyne, as executive stock sales can often be scrutinized for signals regarding the company’s future performance. However, the planned nature of this sale under a Rule 10b5-1 plan may mitigate concerns about insider trading, as it demonstrates a pre-established strategy rather than a reaction to market conditions.
As for what’s next, the filing does not specify any further actions or upcoming filings related to this transaction. Investors and analysts will likely keep an eye on future disclosures from Matz and other executives at Teradyne for additional insights into the company's direction.